FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with
Everything about lung cancer is here.
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with
Lung cancer is one of the most deadly types of cancers in the United States as well as around the
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to
Lung cancer remains the most frequently diagnosed cancer type and is the leading cause of cancer related deaths worldwide. Most
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience